{"id":8899,"date":"2017-04-25T13:16:00","date_gmt":"2017-04-25T17:16:00","guid":{"rendered":"https:\/\/vetanco.com\/en\/?p=8899"},"modified":"2024-09-30T13:25:43","modified_gmt":"2024-09-30T17:25:43","slug":"vedevax-first-recombinant-vaccine-dvb","status":"publish","type":"post","link":"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/","title":{"rendered":"VEDEVAX First recombinant vaccine for DVB"},"content":{"rendered":"\n\n\n<p><strong>Vetanco S.A.<\/strong>, through its subsidiary&nbsp;<strong>Bioinnovo<\/strong>&nbsp;developed and registered in Argentina&nbsp;<strong>the first recombinant vaccine for the control of bovine viral diarrhea virus<\/strong>.&nbsp;<strong>Vedevax<\/strong>, a subunit vaccine produced on a baculovirus line, and potentiated by a routing protein, produces highly protective titles in animals under control of a veterinary professional.&nbsp;<strong>Vedevax<\/strong>&nbsp;is another development of Bioinnovo for the world.<\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"81\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/bioinnovo-logo-finalisimo-alta-300x81-1.jpg\" alt=\"\" class=\"wp-image-8901\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"517\" height=\"1024\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/vedevax-block-1-517x1024-3.png\" alt=\"\" class=\"wp-image-8902\" srcset=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/vedevax-block-1-517x1024-3.png 517w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/vedevax-block-1-517x1024-3-151x300.png 151w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/vedevax-block-1-517x1024-3-510x1010.png 510w\" sizes=\"auto, (max-width: 517px) 100vw, 517px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"254\" height=\"190\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/ib50k2016p2-254x190-1.jpg\" alt=\"\" class=\"wp-image-8903\"\/><\/figure>\n\n\n\n<div class=\"wp-block-group is-nowrap is-layout-flex wp-container-core-group-is-layout-ad2f72ca wp-block-group-is-layout-flex\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"253\" height=\"190\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vedevax-2-253x190-2.jpg\" alt=\"\" class=\"wp-image-8904\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"244\" height=\"190\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vedevax-3-244x190-2.jpg\" alt=\"\" class=\"wp-image-8905\"\/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-group is-nowrap is-layout-flex wp-container-core-group-is-layout-ad2f72ca wp-block-group-is-layout-flex\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"253\" height=\"190\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vedevax-4-253x190-2.jpg\" alt=\"\" class=\"wp-image-8906\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"253\" height=\"190\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vedevax-5-253x190-1.jpg\" alt=\"\" class=\"wp-image-8907\"\/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-group is-nowrap is-layout-flex wp-container-core-group-is-layout-ad2f72ca wp-block-group-is-layout-flex\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"253\" height=\"190\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vedevax-8-253x190-2.jpg\" alt=\"\" class=\"wp-image-8908\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"253\" height=\"190\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vedevax-9-253x190-1.jpg\" alt=\"\" class=\"wp-image-8909\"\/><\/figure>\n\n\n\n<p><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Vetanco S.A., through its subsidiary&nbsp;Bioinnovo&nbsp;developed and registered in Argentina&nbsp;the first recombinant vaccine for the control of bovine viral diarrhea virus.&nbsp;Vedevax, a subunit vaccine produced on a baculovirus line, and potentiated by a routing protein, produces highly protective titles in animals under control of a veterinary professional.&nbsp;Vedevax&nbsp;is another development of Bioinnovo for the world.<\/p>\n","protected":false},"author":8,"featured_media":8910,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[28],"tags":[19,21,161,18,40],"class_list":["post-8899","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-bioinnovo","tag-bovine-viral-diarrhea-virus","tag-vedevax","tag-vetanco","tag-vetanco-s-a"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VEDEVAX First recombinant vaccine for DVB - Vetanco United States<\/title>\n<meta name=\"description\" content=\"Vetanco S.A., through its subsidiary Bioinnovo developed and registered in Argentina the first recombinant vaccine for the control of BVDV.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VEDEVAX First recombinant vaccine for DVB - Vetanco United States\" \/>\n<meta property=\"og:description\" content=\"Vetanco S.A., through its subsidiary Bioinnovo developed and registered in Argentina the first recombinant vaccine for the control of BVDV.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/\" \/>\n<meta property=\"og:site_name\" content=\"Vetanco United States\" \/>\n<meta property=\"article:published_time\" content=\"2017-04-25T17:16:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-30T17:25:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/vedevax-block-1-517x1024-4.png\" \/>\n\t<meta property=\"og:image:width\" content=\"517\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"julian\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"julian\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/\"},\"author\":{\"name\":\"julian\",\"@id\":\"https:\/\/vetanco.com\/en\/#\/schema\/person\/46afb38cfab0fe11bf52a9ded679bfcd\"},\"headline\":\"VEDEVAX First recombinant vaccine for DVB\",\"datePublished\":\"2017-04-25T17:16:00+00:00\",\"dateModified\":\"2024-09-30T17:25:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/\"},\"wordCount\":72,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/vedevax-block-1-517x1024-4.png\",\"keywords\":[\"Bioinnovo\",\"Bovine Viral Diarrhea Virus\",\"Vedevax\",\"Vetanco\",\"Vetanco S.A.\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/\",\"url\":\"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/\",\"name\":\"VEDEVAX First recombinant vaccine for DVB - Vetanco United States\",\"isPartOf\":{\"@id\":\"https:\/\/vetanco.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/vedevax-block-1-517x1024-4.png\",\"datePublished\":\"2017-04-25T17:16:00+00:00\",\"dateModified\":\"2024-09-30T17:25:43+00:00\",\"author\":{\"@id\":\"https:\/\/vetanco.com\/en\/#\/schema\/person\/46afb38cfab0fe11bf52a9ded679bfcd\"},\"description\":\"Vetanco S.A., through its subsidiary Bioinnovo developed and registered in Argentina the first recombinant vaccine for the control of BVDV.\",\"breadcrumb\":{\"@id\":\"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/#primaryimage\",\"url\":\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/vedevax-block-1-517x1024-4.png\",\"contentUrl\":\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/vedevax-block-1-517x1024-4.png\",\"width\":517,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/vetanco.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VEDEVAX First recombinant vaccine for DVB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vetanco.com\/en\/#website\",\"url\":\"https:\/\/vetanco.com\/en\/\",\"name\":\"Vetanco United States\",\"description\":\"Safe Products for Safe Food\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vetanco.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/vetanco.com\/en\/#\/schema\/person\/46afb38cfab0fe11bf52a9ded679bfcd\",\"name\":\"julian\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/vetanco.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bc79426ed0651bb3545f906602e15ffcf6e4bdb7b02b2394b18705841d207f29?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bc79426ed0651bb3545f906602e15ffcf6e4bdb7b02b2394b18705841d207f29?s=96&d=mm&r=g\",\"caption\":\"julian\"},\"url\":\"https:\/\/vetanco.com\/en\/author\/julian\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VEDEVAX First recombinant vaccine for DVB - Vetanco United States","description":"Vetanco S.A., through its subsidiary Bioinnovo developed and registered in Argentina the first recombinant vaccine for the control of BVDV.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/","og_locale":"en_US","og_type":"article","og_title":"VEDEVAX First recombinant vaccine for DVB - Vetanco United States","og_description":"Vetanco S.A., through its subsidiary Bioinnovo developed and registered in Argentina the first recombinant vaccine for the control of BVDV.","og_url":"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/","og_site_name":"Vetanco United States","article_published_time":"2017-04-25T17:16:00+00:00","article_modified_time":"2024-09-30T17:25:43+00:00","og_image":[{"width":517,"height":1024,"url":"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/vedevax-block-1-517x1024-4.png","type":"image\/png"}],"author":"julian","twitter_card":"summary_large_image","twitter_misc":{"Written by":"julian","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/#article","isPartOf":{"@id":"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/"},"author":{"name":"julian","@id":"https:\/\/vetanco.com\/en\/#\/schema\/person\/46afb38cfab0fe11bf52a9ded679bfcd"},"headline":"VEDEVAX First recombinant vaccine for DVB","datePublished":"2017-04-25T17:16:00+00:00","dateModified":"2024-09-30T17:25:43+00:00","mainEntityOfPage":{"@id":"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/"},"wordCount":72,"commentCount":0,"image":{"@id":"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/#primaryimage"},"thumbnailUrl":"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/vedevax-block-1-517x1024-4.png","keywords":["Bioinnovo","Bovine Viral Diarrhea Virus","Vedevax","Vetanco","Vetanco S.A."],"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/","url":"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/","name":"VEDEVAX First recombinant vaccine for DVB - Vetanco United States","isPartOf":{"@id":"https:\/\/vetanco.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/#primaryimage"},"image":{"@id":"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/#primaryimage"},"thumbnailUrl":"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/vedevax-block-1-517x1024-4.png","datePublished":"2017-04-25T17:16:00+00:00","dateModified":"2024-09-30T17:25:43+00:00","author":{"@id":"https:\/\/vetanco.com\/en\/#\/schema\/person\/46afb38cfab0fe11bf52a9ded679bfcd"},"description":"Vetanco S.A., through its subsidiary Bioinnovo developed and registered in Argentina the first recombinant vaccine for the control of BVDV.","breadcrumb":{"@id":"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/#primaryimage","url":"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/vedevax-block-1-517x1024-4.png","contentUrl":"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/vedevax-block-1-517x1024-4.png","width":517,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/vetanco.com\/en\/vedevax-first-recombinant-vaccine-dvb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/vetanco.com\/en\/"},{"@type":"ListItem","position":2,"name":"VEDEVAX First recombinant vaccine for DVB"}]},{"@type":"WebSite","@id":"https:\/\/vetanco.com\/en\/#website","url":"https:\/\/vetanco.com\/en\/","name":"Vetanco United States","description":"Safe Products for Safe Food","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vetanco.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/vetanco.com\/en\/#\/schema\/person\/46afb38cfab0fe11bf52a9ded679bfcd","name":"julian","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vetanco.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bc79426ed0651bb3545f906602e15ffcf6e4bdb7b02b2394b18705841d207f29?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bc79426ed0651bb3545f906602e15ffcf6e4bdb7b02b2394b18705841d207f29?s=96&d=mm&r=g","caption":"julian"},"url":"https:\/\/vetanco.com\/en\/author\/julian\/"}]}},"_links":{"self":[{"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/posts\/8899","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/comments?post=8899"}],"version-history":[{"count":2,"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/posts\/8899\/revisions"}],"predecessor-version":[{"id":11756,"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/posts\/8899\/revisions\/11756"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/media\/8910"}],"wp:attachment":[{"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/media?parent=8899"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/categories?post=8899"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/tags?post=8899"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}